CME Group Reports Q3 2025 Revenue Decline, Year-to-Date Growth

CME Group Inc. reported its financial results for the third quarter and the first nine months of 2025, revealing a slight decline in quarterly revenues but an overall increase in year-to-date performance. For the quarter ended September 30, 2025, total revenues amounted to $1.54 billion, a decrease of 3% from $1.58 billion in the same period last year. However, revenues for the nine months ended September 30, 2025, increased by 6% to $4.87 billion, compared to $4.60 billion in the prior year. The company's net income for the third quarter was $908 million, down from $912.8 million a year earlier, while year-to-date net income rose to $2.89 billion from $2.65 billion.

The decline in quarterly revenues was primarily driven by a 5% decrease in clearing and transaction fees, which totaled $1.23 billion, down from $1.30 billion in the previous year. This was partially offset by a 14% increase in market data and information services revenue, which reached $202.5 million, up from $178.2 million. The company attributed the overall revenue growth for the nine-month period to increased trading volumes and higher interest earned on reinvested cash performance bonds, despite a challenging market environment characterized by geopolitical tensions and fluctuating interest rates.

CME Group has also made strategic moves, including the completion of the sale of its 50% equity investment in OSTTRA to KKR & Co. Inc. for a total enterprise value of $3.1 billion. This transaction is expected to yield a net gain of approximately $300 million in the fourth quarter of 2025. Additionally, the company continues to invest in technology, with a focus on its transition to the Google Cloud, which has driven increases in technology-related expenses.

Operationally, CME Group reported a total average daily contract volume of 25.3 million for the third quarter, a decrease of 10% from 28.3 million in the same quarter of 2024. The decline was attributed to lower market volatility and uncertainty surrounding economic conditions. However, the company noted a 6% increase in average daily volume for the nine-month period, reflecting a recovery in trading activity earlier in the year. The firm’s employee headcount has also increased, reflecting its ongoing investments in technology and international expansion.

Looking ahead, CME Group remains cautiously optimistic about its future performance, emphasizing its ability to adapt to changing market conditions and maintain its competitive position. The company expects to continue generating strong cash flows and is committed to returning value to shareholders through its share repurchase program, which has approximately $2.99 billion remaining for future buybacks. The firm also highlighted its compliance with regulatory requirements and its strong liquidity position, which it believes will support its growth strategy moving forward.